UHRF2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.87350143679532E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.0478000000066E-05 |
Normal-vs-Stage2 |
3.426000E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.143030E-03 |
Stage1-vs-Stage2 |
8.205000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.725600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.495000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.99529997974213E-09 |
Normal-vs-AfricanAmerican |
6.20149998020736E-09 |
Normal-vs-Asian |
1.225910E-02 |
Caucasian-vs-AfricanAmerican |
3.778000E-01 |
Caucasian-vs-Asian |
9.259200E-01 |
AfricanAmerican-vs-Asian |
5.441800E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.80019999999459E-05 |
Normal-vs-Female |
2.19499999953854E-07 |
Male-vs-Female |
6.948400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.881590E-03 |
Normal-vs-Extreme_Weight |
1.83830999999079E-05 |
Normal-vs-Obese |
7.009000E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.603010E-01 |
Normal_Weight-vs-Obese |
7.895800E-03 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.172200E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.493000E-01 |
Normal-vs-Age(41-60Yrs) |
1.158640E-03 |
Normal-vs-Age(61-80Yrs) |
5.79369999753609E-08 |
Normal-vs-Age(81-100Yrs) |
3.938400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.724000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.883000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.936800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.226200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.505800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.629400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.348400E-01 |
Normal-vs-Grade 3 |
8.042000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.506000E-01 |
Grade 2-vs-Grade 4 |
7.348400E-01 |
Grade 3-vs-Grade 4 |
8.042000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.54200000546112E-08 |
Normal-vs-N1 |
2.415300E-03 |
N0-vs-N1 |
4.364300E-02 |
|
|